![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Senseonics Gains CE Mark for Eversense CGM System
Senseonics Gains CE Mark for Eversense CGM System
Senseonics has garnered a CE Mark for its continuous Eversense continuous glucose monitoring system, the Germantown, Md.-based company announced Tuesday.
The implantable device features a transmitter for measuring glucose levels and an app to showcase glucose readings in real-time.
The system, which touts an implanted glucose sensor that can last up to 90 days, removes the need for a weekly sensor insertion used by traditional CGM systems. — Anisa Jibrell
Upcoming Events
-
11Jul
-
18Jul
-
21Oct